Female infertility, infertility-associated diagnoses, and comorbidities: a review

Journal of Assisted Reproduction and Genetics

Volumn 34, Issue 2, 2017, Pages 167-177

  Hanson, Brent ^a   Johnstone, Erica ^b,c   Dorais, Jessie ^b,c   Silver, Bob ^a   Peterson, C Matthew ^b,c   Hotaling, James ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Utah Center for Reproductive Medicine   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Fertility drugs; In vitro fertilization; Infertility; Malignancy; Somatic health

Indexed keywords

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE INFERTILITY; HEALTH CARE PERSONNEL; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; OUTCOME ASSESSMENT; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; ADULT; COMPLICATION; FEMALE; GENITAL NEOPLASMS, FEMALE; IN VITRO FERTILIZATION; INFERTILITY, FEMALE; MENTAL DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; REPRODUCTION;

ADULT; COMORBIDITY; FEMALE; FERTILIZATION IN VITRO; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; MENTAL DISORDERS; POLYCYSTIC OVARY SYNDROME; REPRODUCTION;

EID: 84994351456     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-016-0836-8     Document Type: Review

References (41)

1. Valoriani VFL, Lari D, Miccinesi G, Vaiani S, Vanni C, Coccia ME, et al. Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study. Europ J Obstet Gynecol Reprod Biol. 2016;197:179–85.
2. Veltman-Verhulst S. Emotional distress is a common risk in women with polycystic ovarian syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638–51.
3. Gokhan A. Level of anxiety, depression, self esteem, social anxiety, and quality of life among women with polycystic ovarian syndrome. Sci World J. 2013;2013:7.
4. Jedel E. Anxiety and depression symptoms in women with polycystic ovarian syndrome compared with controls matched for body mass index. Hum Reprod. 2009;25(2):450–6.
5. Baldur-Felskov P. disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod. 2013;28(3):683–90.
6. Hart RDD. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–9.
7. Venn A. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet. 1999;354(9190):1586–90.
8. Barry J. Risk of endometrial, ovarian, and breast CA in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–58.
9. Brinton L. Fertility drugs and endometrial cancer risk: results from an extended follow up from a large infertility cohort. Hum Reprod. 2013;28(10):2813–21.
10. Venn A. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346(8981):995–1000.
11. Lundberg F. Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study. Breast Cancer Res. 2016;18(1):36.
12. Kim J. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population based case-control study. Cancer Causes Control. 2016;27(3):403–14.
13. Gabriele V. Infertility and breast cancer: is there a link? Updated review of the literature and meta-analysis. Gynecol Obstet Fertil. 2016;44(2):113–20.
14. Reigstad M. Risk of breast cancer following fertility treatment—a registry based cohort study of parous women in Norway. Int J Cancer. 2015;136(5):1140–8.
15. Reigstad M. Cancer risk among parous women following assisted reproductive technology. Hum Reprod. 2015;30(8):1952–63.
16. Kvaskoff M. Endometriosis: a high risk population for major chronic diseases? Hum Reprod Update. 2015;21(4):500–16.
17. Luke B. Cancer in women after assisted reproductive technology. Fertil Steril. 2015;104(5):1218–26.
18. Cirillo P. Irregular menses predicts ovarian cancer. Int J Cancer. 2016.
19. Bjornholt S. Risk for borderline ovarian tumors after fertility drugs: results of a population based cohort study. Hum Reprod. 2015;30(1):222–31.
20. Rizzuto I. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013:8.
21. Parikh N. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational Study. Circulation. 2016.
22. Ghaffarzad A. Correlation of serum lipoprotein ratios with insulin resistance in infertile women with PCOS: a case control study. Int J Fertil Steril. 2016;10(1):29–35.
23. El-Hayek. Polycystic ovarian syndrome: an updated overview. Front Physiol. 2016. 7(124).
24. Polat S. Thyroid disorders in young females with PCOS and correlation of thyroid volume with certain hormonal parameters. J Reprod Med. 2016;61(1–2):27–32.
25. Zahiri Z. Metabolic syndrome in patients with polycystic ovarian syndrome in Iran. Int J Fertil Steril. 2016;9(4):490–6.
26. Ramezani-Binabaj M. Are women with polycystic ovarian syndrome at high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon. 2014. 14(11): p.
27. Aghajanova L. Obstetrics and gynecology residency and fertility needs: national survey results. Reprod Sci. 2016.
28. Prevention C.f.D.C.a. Assisted reproductive technology success rates: national summary and fertility clinic reports. US Department of Health and Human Services. 2010.
29. SART, National Summary Report. 2014, Society for Assisted Reproductive Technology: SART Website (www.sart.org).
30. Joshi N. Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstet Gynecol. 2012;120(4):843–51.
31. Tarin J. Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol. 2015. 13(31).
32. Escobedo L. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol. 1991;77(1):124–8.
33. Modan B. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 1998;147(11):1038–42.
34. Althius M. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005;161(7):607–15.
35. Silva-Idos S. Ovulation-stimulation drugs and cancer risks: a long-term follow up of a British cohort. Br J Cancer. 2009;100(11):1824–31.
36. Lerner-Geva L. Are infertility treatments a potential risk factor for cancer development? perspective of 30 years of follow-up. Gynecol Endocrinol. 2012;28(10):809–14.
37. Oktay K. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian CA risks. J Clin Oncol. 2010;28(2):240–4.
38. Phillips K. Anti-mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum Reprod. 2016;31(5):1126–32.
39. Wang E. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014;102(6):1723–8.
40. Opdahl S. Joint effects of nulliparity and other breast cancer risk factors. Br J Cancer. 2011;105(5):731–6.
41. Hu M. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. Proc Natl Acad Sci U S A. 2015;112(46):14348–535.